Diana Brainard
CIK 1818070 · Chief Executive Officer · last filed 2025-10-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.70M
Companies
2
Total Filings
42
Lifetime Open-Market Net
-$569.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NKTR | Director | 28,560 | $59.38 | $1.70M | $0 | 4 | 2025-10-01 |
| Kalaris Therapeutics, Inc. (ALVR) Delisted | Chief Executive Officer | 723,363 | $9.81 | $7.10M | -$569.2K | 38 | 2024-11-20 |
Recent Filings · Page 5 of 5
42 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-08-05 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Buy (P) | +6,300 | $107.1K | EDGAR |
| 2020-07-31 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 41–42 of 42
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.